Safeguarding Patients and Taxpayers Act

Summary

Safeguarding Patients and Taxpayers Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to annually report certain information on its use of funds to implement the Medicare Drug Price Negotiation Program. (The program requires the CMS to negotiate the prices of certain prescription drugs under Medicare beginning in 2026.) Specifically, the CMS must annually report (for as long as funds are available) on the amounts expended, the use of funds, and the projected and actual unused funds from amounts appropriated to implement the program. The CMS must also report on relevant contracts, efforts to prevent fraud, waste, and abuse, and other implementation activities and associated expenditures. The bill also explicitly restricts the CMS from using program funds for other programs or purposes.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 11 May 2023

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 11 May 2023

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 11 May 2023 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 11 May 2023

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 11 May 2023

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 11 May 2023

  Open at official source

Sponsors

• Thomas Tillis · R · Sponsor
• Mitch McConnell · R · Sponsor
• Mike Crapo · R · Sponsor
• Steve Daines · R · Sponsor
• Marsha Blackburn · R · Sponsor
• James Lankford · R · Cosponsor
• · ssfi00 · Standing

Related records

No cross-record relationships stored yet.